Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Net Margin (2020 - 2025)

RxSight (RXST) has disclosed Net Margin for 6 consecutive years, with 91.16% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 10592.0% year-over-year to 91.16%, compared with a TTM value of 0.05% through Dec 2025, up 1957.0%, and an annual FY2025 reading of 0.05%, up 1957.0% over the prior year.
  • Net Margin was 91.16% for Q4 2025 at RxSight, up from 32.35% in the prior quarter.
  • Across five years, Net Margin topped out at 91.16% in Q4 2025 and bottomed at 219.03% in Q3 2021.
  • Average Net Margin over 5 years is 74.21%, with a median of 45.48% recorded in 2023.
  • Peak annual rise in Net Margin hit 49217bps in 2021, while the deepest fall reached -112340bps in 2021.
  • Year by year, Net Margin stood at 186.72% in 2021, then surged by 48bps to 97.05% in 2022, then soared by 67bps to 32.12% in 2023, then skyrocketed by 54bps to 14.77% in 2024, then surged by 717bps to 91.16% in 2025.
  • Business Quant data shows Net Margin for RXST at 91.16% in Q4 2025, 32.35% in Q3 2025, and 35.04% in Q2 2025.